ALK-positive advanced NSCLC

Clinical trials for ALK-positive advanced NSCLC explained in plain language.

Never miss a new study

Get alerted when new ALK-positive advanced NSCLC trials appear

Sign up with your email to follow new studies for ALK-positive advanced NSCLC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

Real-World data reveals how lung cancer drug lorlatinib performs outside the lab

Knowledge-focused Ongoing

This study looks at how patients with ALK-positive advanced non-small cell lung cancer respond to the drug lorlatinib when used as their first treatment in real-world settings. Researchers will analyze data from 200 patients in a U.S. database to see how long they stay on the dru…

Matched conditions: ALK-POSITIVE ADVANCED NSCLC

Sponsor: Pfizer • Aim: Knowledge-focused

Last updated Sep 19, 2026 00:00 UTC

ALK-positive advanced NSCLC

Get alerted when new ALK-positive advanced NSCLC trials appear

Real-World data reveals how lung cancer drug lorlatinib performs outside the lab